Leveraging valine-restriction-induced DNA damage for targeted cancer therapy
Authors:
- 6 February 2025
- journal article
- Published by Elsevier in Molecular Cell
- Vol. 85 (3) , 468-470
Abstract
No abstract availableKeywords
Funding Information
- Neubauer Family Foundation
- ICRF (22-110-PG)
This publication has 10 references indexed in Scilit:
- Human HDAC6 senses valine abundancy to regulate DNA damageNature, 2024
- BRCAness, DNA gaps, and gain and loss of PARP inhibitor–induced synthetic lethalityJournal of Clinical Investigation, 2024
- NBS1 lactylation is required for efficient DNA repair and chemotherapy resistanceNature, 2024
- An evolutionary mechanism to assimilate new nutrient sensors into the mTORC1 pathwayNature Communications, 2024
- Metabolic regulation of homologous recombination repair by MRE11 lactylationCell, 2023
- CDYL1-dependent decrease in lysine crotonylation at DNA double-strand break sites functionally uncouples transcriptional silencing and repairMolecular Cell, 2022
- Targeting cancer metabolism in the era of precision oncologyNature Reviews Drug Discovery, 2021
- Multifaceted role of branched-chain amino acid metabolism in cancerOncogene, 2020
- Oncometabolites suppress DNA repair by disrupting local chromatin signallingNature, 2020
- Nuclear Acetyl-CoA Production by ACLY Promotes Homologous RecombinationMolecular Cell, 2017